H3.3K27M peptide vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for H3.3K27M peptide vaccine, covering 2025-01-22 to 2025-01-22. Get the full timeline:
Most recent: Clinical Trial Update: H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas [Phase 1, Phase 2]